|
CUL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62536650805123E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
4.14140000000174E-05 |
| Normal-vs-Stage3 |
1.15520004673186E-09 |
| Normal-vs-Stage4 |
7.80799980226732E-10 |
| Stage1-vs-Stage2 |
3.216000E-01 |
| Stage1-vs-Stage3 |
6.083400E-01 |
| Stage1-vs-Stage4 |
4.089800E-01 |
| Stage2-vs-Stage3 |
2.281600E-01 |
| Stage2-vs-Stage4 |
1.558430E-01 |
| Stage3-vs-Stage4 |
6.271200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62503344114384E-12 |
| Normal-vs-AfricanAmerican |
3.90030230335014E-11 |
| Normal-vs-Asian |
4.41480000334948E-08 |
| Caucasian-vs-AfricanAmerican |
6.872000E-01 |
| Caucasian-vs-Asian |
3.963400E-01 |
| AfricanAmerican-vs-Asian |
3.426000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.3906000007633E-08 |
| Male-vs-Female |
4.723100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.28529999976479E-07 |
| Normal-vs-Extreme_Weight |
1.22124532708767E-15 |
| Normal-vs-Obese |
2.06101802291414E-12 |
| Normal-vs-Extreme_Obese |
1.18029999995883E-07 |
| Normal_Weight-vs-Extreme_Weight |
2.475600E-01 |
| Normal_Weight-vs-Obese |
9.654400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.773800E-01 |
| Extreme_Weight-vs-Obese |
1.359350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.185800E-01 |
| Obese-vs-Extreme_Obese |
5.633400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.1631000000365E-06 |
| Normal-vs-Age(41-60Yrs) |
3.86357612569554E-14 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
6.33749996925559E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.510000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.396600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.618620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.786190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.908800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.794400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.04589670257837E-11 |
| Normal-VS-KIRP CIMP |
1.486050E-02 |
| Normal-VS-Unclassified PRCC |
2.24580000041108E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.843800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.387400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.859400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.865000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.127600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.508600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4432899320127E-15 |
| Normal-vs-N1 |
4.57800000019937E-07 |
| Normal-vs-N2 |
1.85210002889846E-09 |
| N0-vs-N1 |
3.948000E-01 |
| N0-vs-N2 |
3.839600E-02 |
| N1-vs-N2 |
3.831900E-04 |
|
|
